Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
- Q2 2021 ARCALYST® (rilonacept) net revenue of $7.7 million with greater than 100 prescribing physicians - - Phase 3...
Day: August 3, 2021
aTyr Pharma to Webcast Conference Call Reporting Second Quarter 2021 Financial Results
Management to host conference call and webcast on August 10th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, Aug....
Pliant Therapeutics to Participate in the BTIG Biotechnology Conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
Lumos Pharma Announces Industry Veteran, David B. Karpf, MD, has Joined the Company as Chief Medical Officer
AUSTIN, Texas, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for...
HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission...
Pacific Biosciences Acquires Circulomics – A Leading High Molecular Weight DNA Extraction Company
Technology Will Enable Continued End-to-End Automated Workflow DevelopmentMENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California,...
Mindset Files International Patent Application for its Novel Psilocybin Synthesis Method
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE:9DF) (OTCQB:MSSTF) (“Mindset” or the “Company”), a drug discovery...
Alignment Healthcare Nearly Doubles Geographic Footprint, Expanding into 16 New Markets to Reach 6.9 Million Medicare Enrollees in 2022
ORANGE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Since its debut as a public company earlier this year, award-winning Medicare...
X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results
Twenty-three patients now enrolled in ongoing pivotal Phase 3 trial in WHIM syndrome, surpassing minimum needed for primary endpoint analyses;...
Complete Response Letter Received from FDA for Treosulfan
TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX:...
Tauriga Sciences Inc. Confirms That It’s on Pace for a Strong Quarter From Its Retail Business
The Company’s Current Operating Quarter is Its 2nd Fiscal Quarter 2022 (Period: July 1, 2021 – September 30, 2021) NEW YORK,...
Acerus to Report Q2-2021 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its second quarter 2021 financial and...
OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
- OpGen subsidiary Curetis and its instrument development partner have completed assembly of 10 final pre-series release A30 RQ analyzers...
Matinas BioPharma to Participate in BTIG Virtual Biotechnology Conference
BEDMINSTER, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D....
Neuronetics Reports Second Quarter 2021 Financial and Operating Results
MALVERN, Pa., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru
AUREUS SANTA MARTA by AVICANNA Avicanna Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Peru Believed...
Generation Bio to Present at Wedbush PacGrow Healthcare Conference 2021
CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...
Aurora Spine Corporation Announces FDA 510(k) Clearance for DEXA-C™ Cervical Interbody System
Product approval is the first in the world using Company's proprietary and patented DEXA Technology™ for custom made implants based...
Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans
SALT LAKE CITY, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and...
Former Canadian Armed Forces Surgeon General Brigadier-General (Retired) H. Colin MacKay, OMM, CD, QHP, MD, MHSc, FRCPC (Hon) Joins The Newly Institute
Brigadier-General (Retired) H. Colin MacKay, OMM, CD, QHP, MD, MHSc, FRCPC (hon) was the 39th Canadian Forces Surgeon General. The...